🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › Missouri

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Missouri

Tha 24 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann an Missouri.

Bailtean ann an Missouri

Teacsa sgrùdaidh oifigeil (Beurla)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Washington University Medicine, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Washington University School of Medicine in St. Louis, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  • Washington University, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06799065

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • Washington University, St Louis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • Lake Regional Hospital ( Site 0009), Osage Beach
  • Siteman Cancer Center ( Site 0099), St Louis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Saint Luke's Cancer Institute ( Site 0059), Kansas City
  • Washington University Siteman Cancer Center ( Site 0031), St Louis
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Local Institution - 0140, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06618287

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • Washington University, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06657222

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT03606967

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Oncology Hematology Associates, Springfield
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • Washington University, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07029399

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07115043

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

  • Universtiy Health, Kansas City
  • KCCC South, Kansas City
  • Research Medical Center, Kansas City
  • agus 2 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT02302742

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT07137416

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - SPG, Springfield
  • Mercy Hospital - South, St Louis
  • Mercy Hospital -STL, St Louis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT07327489

A Study of LY4175408 in Participants With Advanced Cancer

  • Washington University, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

  • Siteman Cancer Center, St Louis
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT06545331

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

  • Siteman Cancer Center, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Faoi 2026 · NCT06926920

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

  • Washington University, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Faoi 2026 · NCT05490472

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

  • Washington University, St Louis
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2025 · NCT06682793

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

  • Cox Medical Center, Springfield
A’ fastadhÌre 3
Aoisean 18 gu 65 · Banairean · Air ùrachadh 21 Màrt 2025 · NCT03671044

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.